Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions

European Journal of Neuroscience

Volumn 20, Issue 5, 2004, Pages 1150-1160

  Verge, Gail M ^a   Milligan, Erin D ^b   Maier, Steve F ^b   Watkins, Linda R ^b   Naeve, Gregory S ^a,c   Foster, Alan C ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Parallax Biosystems Inc   (United States)

Author keywords

CX3CL1; CX3CR1; Dorsal horn; Fractalkine; Microglia; Spinal cord

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FUNCTIONAL ANATOMY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INJURY; MALE; MICROGLIA; NERVE CELL; NEUROPATHIC PAIN; NEUROPATHY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SCIATIC NERVE; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL GANGLION; UPREGULATION;

ANIMALS; CHEMOKINES, CX3C; GANGLIA, SPINAL; MALE; MEMBRANE PROTEINS; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOKINE; RECEPTORS, HIV; SPINAL CORD;

EID: 4544252839     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03593.x     Document Type: Article

References (41)

1. Abbadie, C., Lindia, J.A., Cumiskey, A.M., Peterson, L.B., Mudgett, J.S., Bayne, E.K., DeMartino, J.A., MacIntyre, D.E. & Forrest, M.J. (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl Acad. Sci. USA, 100, 7947-7952.
2. Araque, A., Parpura, V., Sanzgiri, R.P. & Haydon, P.G. (1999) Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci., 22, 208-215.
3. Asensio, V.C. & Campbell, I.L. (1999) Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci., 22, 504-512.
4. Bennett, G.J. & Xie, Y.K. (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 33, 87-107.
5. Boehme, S.A., Lio, F.M., Maciejewski-Lenoir, D., Bacon, K.B. & Conlon, P.J. (2000) The chemokine fractalkine inhibits fas-mediated cell death of brain microglia. J. Immunol., 165, 397-403.
6. Buttini, M., Westland, C.E., Masliah, E., Yafeh, A.M., Wyss-Coray, T. & Mucke, L. (1998) Novel role of human CD4 molecule identified in neurodegeneration. Nature Med., 4, 441-446.
7. Chacur, M., Milligan, E.D., Gazda, L.S., Armstrong, C., Wang, H., Tracey, K.J., Maier, S.F. & Watkins, L.R. (2001) A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain, 94, 231-244.
8. Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M. & Yaksh, T.L. (1994) Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods, 53, 55-63.
9. Chapman, G.A., Moores, K., Harrison, D., Campbell, C.A., Steward, B.R. & Strijbos, P.J.L.M. (2000) Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci., 20: RC87 (81-85).
10. Colburn, R.W., DeLeo, J.A., Rickman, A.J., Yeager, M.P., Kwon, P. & Hickey, W.F. (1997) Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J. Neuroimmunol., 79, 163-175.
11. Crocker, P.R., Jefferies, W.A., Clark, S.J., Chung, L.P. & Gordon, S. (1987) Species heterogeneity in macrophage expression of the CD4 antigen. J. Exp. Med., 166, 61361-61368.
12. Eng, L.F. & Lee, Y.L. (2003) Response of chemokine antagonists to inflammation in injured spinal cord. Neurochem. Res., 28, 95-100.
13. Gazda, L.S., Milligan, E.D., Hansen, M.K., Twining, C.M., Paulos, N., Chacur, M., O'Connor, K.A., Armstrong, C. & Maier, S.F. (2001) Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by perisciatic proinflammatory cytokine and superoxide production. J. Peripheral Nerv. Sys., 6, 111-129.
14. Hargreaves, K., Dubner, R., Brown, F., Flores, C. & Joris, J. (1998) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
15. Harrison, J.K., Jiang, Y., Chen, S., Xia, Y., Maciejewski-Lenoir, D., McNamara, R.K., Streit, W.J., Salafranca, M.N., Adhikari, S., Thompson, D.A., Botti, P., Bacon, K.B. & Feng, L. (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl Acad. Sci. USA, 95, 10896-10901.
16. Hughes, P.M., Batham, M.S., Frentzel, S., Mir, A. & Perry, V.H. (2002) Expression of fractalkine (CX3CL1) and its receptor (CX3CR1), during acute and chronic inflammation in the rodent CNS. Glia, 37, 314-327.
17. Jung, S., Aliberti, J., Graemmel, P., Sunshine, M.J., Kreutzberg, G.W., Sher, A. & Littman, D.R. (2000) Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol., 20, 4106-4114.
18. Konsman, J.P., Parnet, P. & Dantzer, R. (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci., 25, 154-159.
19. LaMotte, C., Kapadia, S.E. & Shapiro, C.M. (1991) Central projections of the sciatic, saphenous, median, and ulnar nerves of the rat demonstrated by transganglionic transport of choleraenoid-HRP (B-HRP) and wheat germ agglutinin-HRP (WGA-HRP). J. Comp. Neurol., 311, 546-562.
20. Maciejewski-Lenoir, D., Chen, S., Feng, L., Maki, R. & Bacon, K.B. (1999) Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR1 expressing microglia. J. Immunol., 163, 1628-1635.
21. Meller, S.T., Dykstra, C., Grzbycki, D., Murphy, S. & Gebhart, G.F. (1994) The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology, 33, 1471-1478.
22. Milligan, E.D., Maier, S.F. & Watkins, L.R. (2004) Sciatic inflammatory neuropathy in the rat: surgical procedures, induction of inflammation, and behavioral testing. In Luo, D. (Ed.), Pain Research Methods and Protocols: Methods of Molecular Medicine, Vol. 99. Humana Press, New York, pp. 67-89.
23. Milligan, E.D., Mehmert, K.K., Hinde, J.L., Harvey, L.O.J., Martin, D., Tracey, K.J., Maier, S.F. & Watkins, L.R. (2000) Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the Human Immunodeficiency Virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res., 861, 105-116.
24. Milligan, E.D., O'Connor, K.A., Nguyen, K.T., Armstrong, C.B., Twining, C., Gaykema, R., Holguin, A., Martin, D., Maier, S.F. & Watkins, L.R. (2001) Intrathecal HIV-1 envelope glycoprotein gp120 enhanced pain states mediated by spinal cord proinflammatory cytokines. J. Neurosci., 21, 2808-2819.
25. Milligan, E.D., Twining, C., Chacur, M., Tracey, K., Martin, D., Poole, S., Maier, S.F. & Watkins, L.R. (2003) Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain. J. Neurosci., 23, 1026-1040.
26. Milligan, E.D., Verge, G., Twining, C., Chapman, G., Maier, S.F., Naeve, G., Martin, D. & Watkins, L.R. (2002) The potential role of fractalkine, a neural chemokine in creating spinally mediated exaggerated pain states. [American Pain Society Annual Meeting, Baltimore, MD. Poster no. 716.] American Pain Society, Glenview, IL.
27. Nishiyori, A., Minami, M., Ohtani, Y., Takami, S., Yamamoto, J., Kawaguchi, N., Kume, T., Akaike, A. & Satoh, K. (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett., 429, 167-172.
28. Raghavendra, V., Tanga, F. & DeLeo, J.A. (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther., 306, 624-630.
29. Rutkowski, M.D., Winkelstein, B.A., Hickey, W.F., Pahl, J.L. & DeLeo, J.A. (2002) Lumbar nerve root injury induces central nervous system neuroimmune activation and neuroinflammation in the rat: relationship to painful radiculopathy. Spine, 27, 1604-1613.
30. Schwaeble, W.J., Stover, C.M., Schall, T.J., Dairaghi, D.J., Trinder, P.K., Linington, C., Iglesias, A., Schubart, A., Lynch, N.J., Weihe, E. & Schafer, M.K. (1998) Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett., 439, 203-207.
31. Stuesse, S.L., Cruce, W.L., Lovell, J.A., McBurney, D.L. & Crisp, T. (2000) Microglial proliferation in the spinal cord of aged rats with a sciatic nerve injury. Neurosci. Lett., 287, 121-124.
32. Sweitzer, S.M., White, K.A., Dutta, C. & DeLeo, J.A. (2002) The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents. J. Neuroimmunol., 125, 82-93.
33. Tarozzo, G., Bortolazzi, S., Crochemore, C., Chen, S.-C., Lira, A.S., Abrams, J.S. & Beltramo, M. (2003) Fractalkine protein localization and gene expression in mouse brain. J. Neurosci. Res., 73, 81-88.
34. Tikka, T.M. & Koistinaho, J.E. (2001) Minocycline provides neuroprotection against N methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol., 166, 7527-7533.
35. Twining, C.M., Schoeniger, D.K., Milligan, E.D., Martin, D., Pettey, C., Maier, S.F. & Watkins, L.R. (2002) Peri-sciatic proinflammatory cytokines mediate allodynia induced by sciatic inflammatory neuropathy (SIN). [Society for Neuroscience Annual Meeting, Orlando, FL.] Soc. Neurosci. Abstr. Poster no. 455.2.
36. Watkins, L.R. & Maier, S.F. (2003) Glia: a novel drug discovery target for clinical pain. Nature Rev. Drug Discovery, 2, 973-985.
37. Watkins, L.R., Milligan, E.D. & Maier, S.F. (2001) Glial activation: a driving force for pathological pain. Trends Neurosci., 24, 450-455.
38. Watkins, L.R., Milligan, E.D., Twining, C.M., Chapman, G.A., O'Connor, K.A. & Maier, S.F. (2002) Spinal fractalkine: key player in exaggerated pain states. [10th World Congress on Pain, San Diego, CA.] International Association for the Study of Pain, Seattle, WA. Poster no. 390-P24.
39. Xia, M. & Hyman, B.T. (1999) Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol., 5, 32-41.
40. Zimmermann, M. (2001) Pathobiology of neuropathic pain. Eur. J. Pharmacol., 429, 23-37.
41. Zujovic, V., Benavides, J., Vigé, X., Carter, C. & Taupin, V. (2000) Fractalkine modulates TNF-α secretion and neurotoxicity induced by microglial activation. Glia, 29, 305-315.